Kezar Life Sciences (KZR) Short Interest Ratio & Short Volume → Who are Nvidia’s Silent Partners? (From Weiss Ratings) (Ad) Free KZR Stock Alerts $0.72 +0.03 (+4.35%) (As of 06/10/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends Kezar Life Sciences Short Interest DataCurrent Short Interest3,710,000 sharesPrevious Short Interest4,150,000 sharesChange Vs. Previous Month-10.60%Dollar Volume Sold Short$2.87 millionShort Interest Ratio4.7 Days to CoverLast Record DateMay 15, 2024Outstanding Shares72,800,000 sharesPercentage of Shares Shorted5.10%Today's Trading Volume558,472 sharesAverage Trading Volume668,666 sharesToday's Volume Vs. Average84% Short Selling Kezar Life Sciences ? Sign up to receive the latest short interest report for Kezar Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartKZR Short Interest Over TimeKZR Days to Cover Over TimeKZR Percentage of Float Shorted Over Time Ad Sasco Gold LLCDon’t make this retirement mistakeIf you have over $100,000 in your 401K or IRA… Then listen closely… Your money is rotting away, and you might not even realize it.Reserve your seat here. Kezar Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20243,710,000 shares $2.87 million -10.6%N/A4.7 $0.77 4/30/20244,150,000 shares $3.42 million +8.6%N/A5.3 $0.82 4/15/20243,820,000 shares $3.09 million +7.0%N/A5.1 $0.81 3/31/20243,570,000 shares $3.22 million +5.6%N/A5 $0.90 3/15/20243,380,000 shares $2.97 million +6.3%N/A4.9 $0.88 2/29/20243,180,000 shares $3.34 million +6.0%N/A4.5 $1.05 Get the Latest News and Ratings for KZR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kezar Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 2/15/20243,000,000 shares $2.53 million -1.6%N/A4.3 $0.84 1/31/20243,050,000 shares $3.02 million +2.4%N/A4.7 $0.99 1/15/20242,980,000 shares $2.77 million +9.6%N/A4.7 $0.93 12/31/20232,720,000 shares $2.58 million +0.7%N/A3.8 $0.95 12/15/20232,700,000 shares $2.26 million +7.6%N/A3.8 $0.84 11/30/20232,510,000 shares $2.10 million -8.7%N/A4.1 $0.84 11/15/20232,750,000 shares $2.18 million +25.0%N/A5.2 $0.79 10/31/20232,200,000 shares $1.59 million -24.9%N/A4.5 $0.72 10/15/20232,930,000 shares $2.80 million -0.7%N/A6.2 $0.96 9/30/20232,950,000 shares $3.51 million +1.0%N/A6.1 $1.19 9/15/20232,920,000 shares $3.77 million +21.7%N/A7.2 $1.29 8/31/20232,400,000 shares $3.58 million -2.8%N/A3.9 $1.49 8/15/20232,470,000 shares $3.80 million -1.6%N/A3.6 $1.54 7/31/20232,510,000 shares $5.62 million -6.0%N/A3.5 $2.24 7/15/20232,670,000 shares $6.49 million -4.0%N/A3.2 $2.43 6/30/20232,780,000 shares $6.81 million -12.0%N/A3 $2.45 6/15/20233,160,000 shares $8.34 million +10.1%N/A2.8 $2.64 5/31/20232,870,000 shares $7.98 million -2.4%N/A2.7 $2.78 5/15/20232,940,000 shares $8.85 million -14.8%N/A2.9 $3.01 4/30/20233,450,000 shares $8.38 million -6.3%N/A3.5 $2.43 4/15/20233,680,000 shares $8.76 million -30.6%N/A3.8 $2.38 3/31/20235,300,000 shares $16.59 million +8.4%N/A5.6 $3.13 3/15/20234,890,000 shares $22.54 million +13.2%N/A6.8 $4.61 2/28/20234,320,000 shares $27.17 million +3.4%N/A6.7 $6.29 2/15/20234,180,000 shares $27.42 million -5.6%N/A7 $6.56 1/31/20234,430,000 shares $31.76 million +14.5%N/A6.9 $7.17 1/15/20233,870,000 shares $26.47 million -37.0%N/A6 $6.84 12/30/20226,140,000 shares $43.23 million -4.5%N/A9.3 $7.04 12/15/20226,430,000 shares $43.60 million -0.3%N/A8.8 $6.78 11/30/20226,450,000 shares $50.37 million -2.3%N/A7.7 $7.81 11/15/20226,600,000 shares $52.93 million -7.3%N/A7.7 $8.02 10/31/20227,120,000 shares $53.51 million +10.9%N/A8.1 $7.52 10/15/20226,420,000 shares $53.61 million -13.0%N/A6.8 $8.35 9/30/20227,380,000 shares $63.54 million +3.4%N/A7.9 $8.61Shocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. 9/15/20227,140,000 shares $70.19 million +2.3%N/A3.3 $9.83 8/31/20226,980,000 shares $71.75 million +0.4%N/A3.3 $10.28 8/15/20226,950,000 shares $74.71 million +24.3%N/A3.2 $10.75 7/31/20225,590,000 shares $54.61 million +4.1%N/A2.5 $9.77 7/15/20225,370,000 shares $55.15 million -7.3%N/A2.3 $10.27 6/30/20225,790,000 shares $47.88 million +29.0%N/A2.4 $8.27 6/15/20224,490,000 shares $21.46 million +4.4%N/A3.7 $4.78 5/31/20224,300,000 shares $21.72 million +19.4%N/A3.8 $5.05 5/15/20223,600,000 shares $20.70 million -14.7%N/A3.5 $5.75 4/30/20224,220,000 shares $50.13 million +13.4%8.9%5 $11.88 4/15/20223,720,000 shares $55.76 million -6.5%7.8%5.9 $14.99 3/31/20223,980,000 shares $66.15 million +5.9%8.3%6.3 $16.62 3/15/20223,760,000 shares $52.64 million +1.6%7.9%6.5 $14.00 2/28/20223,700,000 shares $54.95 million +5.1%7.8%7 $14.85 2/15/20223,520,000 shares $53.61 million -6.6%7.4%5.4 $15.23 1/31/20223,770,000 shares $49.69 million +1.9%8.3%2.4 $13.18 1/15/20223,700,000 shares $52.54 million +5.1%9.3%2.4 $14.20 12/31/20213,520,000 shares $58.85 million +7.7%8.9%2.4 $16.72 12/15/20213,270,000 shares $41.86 million -8.9%8.2%2.3 $12.80 11/30/20213,590,000 shares $49.76 million +99.4%9.1%2.7 $13.86 11/15/20211,800,000 shares $15.14 million -21.4%4.6%1.5 $8.41 10/29/20212,290,000 shares $18.32 million +12.3%5.8%8.3 $8.00 10/15/20212,040,000 shares $17.83 million -1.9%5.2%7.3 $8.74 9/30/20212,080,000 shares $17.97 million +11.8%5.3%8 $8.64 9/15/20211,860,000 shares $16.91 million +8.1%4.7%7.1 $9.09 8/31/20211,720,000 shares $13.11 million -29.8%4.4%7.6 $7.62 8/13/20212,450,000 shares $14.38 million -4.3%6.2%14.1 $5.87 7/30/20212,560,000 shares $12.47 million -1.5%6.4%14.9 $4.87 7/15/20212,600,000 shares $13.47 million -0.8%6.6%13.2 $5.18 6/30/20212,620,000 shares $14.23 million -6.4%6.7%13 $5.43 6/15/20212,800,000 shares $15.79 million -5.1%7.1%10.2 $5.64 5/28/20212,950,000 shares $16.87 million -5.5%7.5%10.6 $5.72 5/14/20213,120,000 shares $16.07 million -8.0%N/A10.8 $5.15 4/30/20213,390,000 shares $19.42 million +0.3%N/A10.2 $5.73 4/15/20213,380,000 shares $20.85 million +65.7%N/A11.5 $6.17 3/31/20212,040,000 shares $12.10 million +4.1%N/A7 $5.93 3/15/20211,960,000 shares $13.33 million +11.4%N/A8.8 $6.80 2/26/20211,760,000 shares $9.77 million +4.8%N/A8.2 $5.55 2/12/20211,680,000 shares $10.18 million +43.6%N/A7.3 $6.06 1/29/20211,170,000 shares $6.34 million -2.5%N/A5.9 $5.42 1/15/20211,200,000 shares $6.84 million -36.5%N/A6.5 $5.70 12/31/20201,890,000 shares $10.09 million +17.4%N/A10.5 $5.34 12/15/20201,610,000 shares $8.90 million -5.9%N/A8.5 $5.53 11/30/20201,710,000 shares $10.16 million -6.0%N/A8.7 $5.94 11/15/20201,820,000 shares $10.06 million +6.4%N/A9.3 $5.53 10/30/20201,710,000 shares $9.15 million +11.8%N/A9.3 $5.35 10/15/20201,530,000 shares $8.26 million +2.0%N/A7.7 $5.40 9/30/20201,500,000 shares $7.26 million +7.9%N/A6.7 $4.84 9/15/20201,390,000 shares $6.82 million +10.3%N/A4.4 $4.91 8/31/20201,260,000 shares $6.12 million -2.3%N/A2.9 $4.86Shocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. 8/14/20201,290,000 shares $5.78 million -4.4%N/A1.5 $4.48 7/31/20201,350,000 shares $5.90 million No ChangeN/A1.6 $4.37 7/15/20201,350,000 shares $6.63 million -0.7%N/A1.6 $4.91 6/30/20201,360,000 shares $7.43 million +162.6%N/A1.6 $5.46 6/15/2020517,900 shares $2.57 million +72.7%N/A0.7 $4.96 5/29/2020299,900 shares $1.57 million -67.1%N/A0.5 $5.25 5/15/2020910,900 shares $4.70 million -6.2%N/A4 $5.16 4/30/2020971,400 shares $4.57 million -1.1%N/A3.4 $4.70 4/15/2020982,500 shares $4.31 million -0.9%N/A3.2 $4.39 3/31/2020991,800 shares $4.66 million +4.9%N/A3.3 $4.70 3/13/2020945,200 shares $3.97 million +8.4%8.5%4.5 $4.20 2/28/2020871,800 shares $3.89 million -1.3%7.8%3.2 $4.46 2/14/2020883,500 shares $3.63 million -4.1%N/A3.5 $4.11 1/31/2020921,700 shares $4.87 million +7.9%9.3%4.4 $5.28 1/15/2020854,200 shares $4.48 million +2.3%6.2%6.7 $5.25 12/31/2019835,200 shares $2.58 million +4.5%7.2%6.9 $3.09 8/15/20191,126,200 shares $4.54 million +0.8%10.1%9.6 $4.03 KZR Short Interest - Frequently Asked Questions What is Kezar Life Sciences' current short interest? Short interest is the volume of Kezar Life Sciences shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 3,710,000 shares of KZR short. Learn More on Kezar Life Sciences' current short interest. What is a good short interest ratio for Kezar Life Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KZR shares currently have a short interest ratio of 5.0. Learn More on Kezar Life Sciences's short interest ratio. Is Kezar Life Sciences' short interest increasing or decreasing? Kezar Life Sciences saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 3,710,000 shares, a drop of 10.6% from the previous total of 4,150,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Kezar Life Sciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Kezar Life Sciences: NextCure, Inc. (0.43%), Hookipa Pharma Inc (1.11%), Omeros Co. (24.44%), Zevra Therapeutics, Inc. (6.45%), Inventiva S.A. (0.13%), Greenwich LifeSciences, Inc. (3.03%), Puma Biotechnology, Inc. (8.63%), Cartesian Therapeutics, Inc. (13.69%), Trevi Therapeutics, Inc. (1.40%), Capricor Therapeutics Inc (13.23%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Kezar Life Sciences stock? Short selling KZR is an investing strategy that aims to generate trading profit from Kezar Life Sciences as its price is falling. KZR shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Kezar Life Sciences? A short squeeze for Kezar Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KZR, which in turn drives the price of the stock up even further. How often is Kezar Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KZR, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: NextCure Short Interest Data Hookipa Pharma Short Interest Data Omeros Short Interest Data Zevra Therapeutics Short Interest Data Inventiva Short Interest Data Greenwich LifeSciences Short Interest Data Puma Biotechnology Short Interest Data Cartesian Therapeutics Short Interest Data Trevi Therapeutics Short Interest Data Capricor Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KZR) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersDON’T buy gold until you read thisIf you're an American who understands that your money is rotting away as you read this email… Then this is ...Sasco Gold LLC | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kezar Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kezar Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.